Adjei, Alex A.
LoRusso, Patricia
Ribas, Antoni
Sosman, Jeffrey A.
Pavlick, Anna
Dy, Grace K.
Zhou, Xiaofei
Gangolli, Esha
Kneissl, Michelle
Faucette, Stephanie
Neuwirth, Rachel
Bózon, Viviana
Article History
Received: 19 July 2016
Accepted: 6 September 2016
First Online: 21 September 2016
Compliance with ethical standards
:
: AR has acted as a consultant for and has received honoraria from Amgen, Compugen, Flexus, GSK, Genentech, and Merck, and holds stock in Novartis and Kite Pharma. JAS has acted as a consultant for Millennium Pharmaceuticals, Inc., Merck, and Amgen, and has received honorarium from Millennium Pharmaceuticals, Inc. The institution of JAS has also received grants from Bristol-Myers Squibb, GSK, and Millennium Pharmaceuticals, Inc. XZ, SF, RN, MK, EG and VB were employees of Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited. AAA, PL, AP, and GKD have no conflicts of interest to disclose.
: The work was supported by Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.